Drugs / TTK
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00674258 | May 2008 → Apr 2009 | non-small cell lung carcinoma | Tokyo University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TTK | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00674258 ↗ |
| Modality | Vaccine | “Peptide Vaccine” NCT00674258 ↗ |
| Route | Subcutaneous | “administered by subcutaneous injection” NCT00674258 ↗ |